Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP386770.RAFOTu3g-c_NVYlAse5_ZH1oblpWYo_dce9_ImVsx3mVU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP386770.RAFOTu3g-c_NVYlAse5_ZH1oblpWYo_dce9_ImVsx3mVU130_assertion type Assertion NP386770.RAFOTu3g-c_NVYlAse5_ZH1oblpWYo_dce9_ImVsx3mVU130_head.
- NP386770.RAFOTu3g-c_NVYlAse5_ZH1oblpWYo_dce9_ImVsx3mVU130_assertion description "[Caspase-3 activity and the expression of four types of TRAIL receptor mRNAs were quantitated in tumor and contiguous non-tumor tissues obtained from 27 patients with HCC (HBV-related in 10; HCV-related in 17).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP386770.RAFOTu3g-c_NVYlAse5_ZH1oblpWYo_dce9_ImVsx3mVU130_provenance.
- NP386770.RAFOTu3g-c_NVYlAse5_ZH1oblpWYo_dce9_ImVsx3mVU130_assertion evidence source_evidence_literature NP386770.RAFOTu3g-c_NVYlAse5_ZH1oblpWYo_dce9_ImVsx3mVU130_provenance.
- NP386770.RAFOTu3g-c_NVYlAse5_ZH1oblpWYo_dce9_ImVsx3mVU130_assertion SIO_000772 12632104 NP386770.RAFOTu3g-c_NVYlAse5_ZH1oblpWYo_dce9_ImVsx3mVU130_provenance.
- NP386770.RAFOTu3g-c_NVYlAse5_ZH1oblpWYo_dce9_ImVsx3mVU130_assertion wasDerivedFrom befree-2016 NP386770.RAFOTu3g-c_NVYlAse5_ZH1oblpWYo_dce9_ImVsx3mVU130_provenance.
- NP386770.RAFOTu3g-c_NVYlAse5_ZH1oblpWYo_dce9_ImVsx3mVU130_assertion wasGeneratedBy ECO_0000203 NP386770.RAFOTu3g-c_NVYlAse5_ZH1oblpWYo_dce9_ImVsx3mVU130_provenance.